Literature DB >> 26277358

Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?

Kristian Aquilina1, David J Daniels2,3, Helen Spoudeas4, Kim Phipps1, Hoong-Wei Gan4, Frederick A Boop5,6,7.   

Abstract

PURPOSE: Unlike pilocytic astrocytomas in other parts of the brain, optic pathway gliomas (OPG) are usually diffuse lesions involving the anterior optic pathways and hypothalamus. Their infiltrative nature often precludes complete surgical resection. We sought to determine whether careful magnetic resonance (MR) analysis, correlated with visual deficits, could be sufficient to identify those focal lesions that may be amenable to more aggressive surgical resection at presentation.
METHODS: We retrospectively reviewed the medical records of patients from two sites: children under 20 years of age treated for OPG between 1985 and 2009 at St Jude's Children's Research Hospital and children under 16 years of age treated at Great Ormond Street Hospital, London, UK, between 1984 and 2011. Patients with isolated optic nerve tumors were excluded. Visual acuity and visual field data at presentation were reviewed and correlated with MR characteristics, including extent of optic pathway involvement, symmetry, and lateral extension.
RESULTS: Two hundred and one children were treated for OPG between 1984 and 2011 in the two institutions; 74 had neurofibromatosis 1 (NF1). At presentation, visual loss was symmetrical in 132 patients and asymmetrical in 69. Potential correlation between pattern of visual loss and tumor characteristics on routine MRI was found in only 13 patients with asymmetrical vision. There was no difference between patients with and without NF1.
CONCLUSION: The decision for aggressive surgical resection for optic pathway gliomas should be based on clinical criteria, particularly in children with good vision in one eye and poor vision in the other, as current MRI results do not reliably predict visual field deficits.

Entities:  

Keywords:  Magnetic resonance; Optic nerve; Optic pathway glioma; Pediatric tumors; Visual deficits; Visual loss

Mesh:

Year:  2015        PMID: 26277358     DOI: 10.1007/s00381-015-2855-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  39 in total

1.  Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.

Authors:  M M Silva; S Goldman; G Keating; M A Marymont; J Kalapurakal; T Tomita
Journal:  Pediatr Neurosurg       Date:  2000-09       Impact factor: 1.162

2.  Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital.

Authors:  A Gajjar; R A Sanford; R Heideman; J J Jenkins; A Walter; Y Li; J W Langston; M Muhlbauer; J M Boyett; L E Kun
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

3.  Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.

Authors:  Karine Jacob; Dongh-Anh Quang-Khuong; David T W Jones; Hendrik Witt; Sally Lambert; Steffen Albrecht; Olaf Witt; Catherine Vezina; Margret Shirinian; Damien Faury; Miklos Garami; Peter Hauser; Almos Klekner; Laszlo Bognar; Jean-Pierre Farmer; Jose-Luis Montes; Jeffrey Atkinson; Cynthia Hawkins; Andrey Korshunov; V Peter Collins; Stefan M Pfister; Uri Tabori; Nada Jabado
Journal:  Clin Cancer Res       Date:  2011-05-24       Impact factor: 12.531

4.  Diffusion tensor imaging of the pediatric optic nerve: intrinsic and extrinsic pathology compared to normal controls.

Authors:  Joshua P Nickerson; Michael B Salmela; Chris J Koski; Trevor Andrews; Christopher G Filippi
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity.

Authors:  G G Grabenbauer; U Schuchardt; M Buchfelder; C M Rödel; G Gusek; M Marx; H G Doerr; R Fahlbusch; W J Huk; D Wenzel; R Sauer
Journal:  Radiother Oncol       Date:  2000-03       Impact factor: 6.280

6.  Significant improvement of visual functions after removal of an intracranial giant optic nerve glioma revealing exophytic growth: case report.

Authors:  Zhiyong Tong; Masahiko Wanibuchi; Teiji Uede; Sumiyoshi Tanabe; Kazuo Hashi
Journal:  Neurosurgery       Date:  2006-04       Impact factor: 4.654

7.  A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.

Authors:  P G Fisher; S N Breiter; B S Carson; M D Wharam; J A Williams; J D Weingart; D R Foer; P T Goldthwaite; T Tihan; P C Burger
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

Review 8.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

9.  Feasibility and advisability of resections of thalamic tumors in pediatric patients.

Authors:  A Leland Albright
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

10.  Surgery of giant gliomas of chiasma and IIIrd ventricle.

Authors:  A Konovalov; S Gorelyshev; N Serova
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

View more
  9 in total

1.  Long-term visual acuity outcomes after radiation therapy for sporadic optic pathway glioma.

Authors:  Sahaja Acharya; Sophia Quesada; Kenneth Coca; Cody Richardson; Mary E Hoehn; Jason Chiang; Ibrahim Qaddoumi; Frederick A Boop; Amar Gajjar; Thomas E Merchant
Journal:  J Neurooncol       Date:  2019-08-14       Impact factor: 4.130

2.  Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas.

Authors:  Sarah Zakaib Rassi; Luis H Ospina; Ariane Bochereau; Yvan Samson; Sébastien Perreault; Dave Saint-Amour
Journal:  Doc Ophthalmol       Date:  2019-06-26       Impact factor: 2.379

Review 3.  Optic Pathway-Hypothalamic Glioma Apoplexy: A Report of Two Cases and Systematic Review of the Literature.

Authors:  Saleh Baeesa; Yazid Maghrabi; Rana Moshref; Jaudah Al-Maghrabi
Journal:  Front Surg       Date:  2022-05-30

4.  Predicting pediatric optic pathway glioma progression using advanced magnetic resonance image analysis and machine learning.

Authors:  Jared M Pisapia; Hamed Akbari; Martin Rozycki; Jayesh P Thawani; Phillip B Storm; Robert A Avery; Arastoo Vossough; Michael J Fisher; Gregory G Heuer; Christos Davatzikos
Journal:  Neurooncol Adv       Date:  2020-08-01

Review 5.  Neurosurgical experience of managing optic pathway gliomas.

Authors:  Ciaran Scott Hill; Mehdi Khan; Kim Phipps; Katherine Green; Darren Hargrave; Kristian Aquilina
Journal:  Childs Nerv Syst       Date:  2021-02-03       Impact factor: 1.475

6.  Comparison of multiple tractography methods for reconstruction of the retinogeniculate visual pathway using diffusion MRI.

Authors:  Jianzhong He; Fan Zhang; Guoqiang Xie; Shun Yao; Yuanjing Feng; Dhiego C A Bastos; Yogesh Rathi; Nikos Makris; Ron Kikinis; Alexandra J Golby; Lauren J O'Donnell
Journal:  Hum Brain Mapp       Date:  2021-05-12       Impact factor: 5.399

7.  Delineation of the visual pathway in paediatric optic pathway glioma patients using probabilistic tractography, and correlations with visual acuity.

Authors:  Patrick W Hales; Victoria Smith; Deepi Dhanoa-Hayre; Patricia O'Hare; Kshitij Mankad; Felice d'Arco; Jessica Cooper; Ramneek Kaur; Kim Phipps; Richard Bowman; Darren Hargrave; Christopher Clark
Journal:  Neuroimage Clin       Date:  2017-10-11       Impact factor: 4.881

Review 8.  A systematic review of ongoing clinical trials in optic pathway gliomas.

Authors:  Ciaran Scott Hill; Sara Castro Devesa; William Ince; Anouk Borg; Kristian Aquilina
Journal:  Childs Nerv Syst       Date:  2020-06-18       Impact factor: 1.475

9.  Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study.

Authors:  Lucia De Martino; Stefania Picariello; Silvia Triarico; Nicola Improda; Pietro Spennato; Michele Antonio Capozza; Anna Grandone; Claudia Santoro; Daniela Cioffi; Giorgio Attinà; Giuseppe Cinalli; Antonio Ruggiero; Lucia Quaglietta
Journal:  Diagnostics (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.